Is it time for clinical trials of invasive group A and groups C and G Streptococcus infections?

On behalf of the Australasian Society for Infectious Diseases Clinical Research Network

doi:10.1016/j.cmi.2023.05.023

Is it time for clinical trials of invasive group A and groups C and G Streptococcus infections?

On behalf of the Australasian Society for Infectious Diseases Clinical Research Network

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1205-1207
Number of pages	3
Journal	Clinical Microbiology and Infection
Volume	29
Issue number	9
DOIs	https://doi.org/10.1016/j.cmi.2023.05.023
Publication status	Published - Sept 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.cmi.2023.05.023

Cite this

@article{92c2f504a4cb4c85906438b79a7fda0a,

title = "Is it time for clinical trials of invasive group A and groups C and G Streptococcus infections?",

author = "{On behalf of the Australasian Society for Infectious Diseases Clinical Research Network} and Ravindra Dotel and Bowen, {Asha C.} and Ouli Xie and Gibney, {Katherine B.} and Carapetis, {Jonathan R.} and Davis, {Joshua S.} and Tong, {Steven Y.C.}",

year = "2023",

month = sep,

doi = "10.1016/j.cmi.2023.05.023",

language = "English",

volume = "29",

pages = "1205--1207",

journal = "Clinical Microbiology and Infection",

issn = "1198-743X",